The A2 Milk Company Ltd (ASX: A2M) share price may be under pressure today following heavy insider selling, but not all executives have been selling shares this week.
The Polynovo Ltd (ASX: PNV) share price is storming higher on Friday after revealing a significant purchase of shares from an insider.
At the time of writing the medical device company’s shares are up an impressive 11% to $2.25.
What did PolyNovo announce?
This morning the medical device company released a change of director’s interests notice which revealed that its chairman has taken advantage of recent share price weakness to add to his holding.
According to the notice, David Williams bought 500,000 shares through an on market trade on 27 August for an average of ~$2.04 per share. This equates to a total consideration of approximately $1,020,000.
Following the purchase, Mr Williams owns a total of 18,500,000 PolyNovo shares.
FY 2020 performance.
Judging by this purchase, it appears as though the chairman is confident the company will build on its performance in FY 2020.
For the 12 months ended 30 June 2020, the dermal regeneration solutions-focused medical device company delivered sales revenue growth of 104% to $19.1 million.
Management advised that this was driven by strong growth across all markets, but particularly in the United States. Thanks to the increasing popularity of its NovoSorb BTM product, the US business delivered a record quarterly sales result in the March quarter. It then followed this up with a 36% increase in sales during the June quarter.
Pleasingly, the company advised that it has been building a solid revenue base in trauma, reconstructive surgery, hand surgery, necrotising fasciitis, and general surgery. Furthermore, its Burn sales are also strong, with significant account penetration in accredited burn centres in all regions.
This appears to have positioned the company perfectly for more of the same in the year ahead.
Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- Why Costa, Flight Centre, Polynovo, & Pointsbet shares are storming higher
- Polynovo share price sinks lower despite doubling sales in FY 2020
- Mesoblast share price on watch after US regulatory approval
- Down 37% in 2 days! Is the Mesoblast share price a buy?
- Is the CSL share price the best ASX biotech buy right now?
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Polynovo share price rockets higher on insider buying news appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2YEjgsc
Leave a Reply